| Identification | |
| Name: | Card-20(22)-enolide,3-[(6-deoxy-a-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxy-,(1b,3b,5b,11a)- |
| Synonyms: | Ouabain(8CI); Acocantherin; Astrobain; Gratibain; Gratus strophanthin; Kombetin; NSC25485; Ouabaine; Purostrophan; Rectobaina; Solufantina; Strodival; Strophalen;Strophoperm; Strophosan; Uabaina; Uabanin; g-Strophanthin; g-Strophicor |
| CAS: | 630-60-4 |
| EINECS: | 211-139-3 |
| Molecular Formula: | C29H44 O12 |
| Molecular Weight: | 584.73 |
| InChI: | InChI=1/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h12,14H,2-11,15-17H2,1H3,(H,19,20) |
| Molecular Structure: |  |
| Properties | |
| Transport: | UN 1544 6.1/PG 1 |
| Melting Point: | 200 DEG C |
| Flash Point: | 306°C |
| Boiling Point: | 409.3°C at 760 mmHg |
| Density: | 0.897g/cm3 |
| Refractive index: | -32 ° (C=1, H2O) |
| Solubility: | SLIGHTLY SOL IN WATER AT 20 DEG C, SOL IN HOT WATER SOL IN ALCOHOL |
| Appearance: | Odorless, white crystals or crystalline powder as an octahydrate |
| Specification: |
Ouabain (630-60-4) is a odorless, white crystals or crystalline powder as an octahydrate. Used to produce rapid digitalization in acute congestive heart failure. Also recommended in treatment of atrial or nodal paroxysmal tachycardia and atrial flutter. |
| Report: |
EPA Extremely Hazardous Substances List. Reported in EPA TSCA Inventory. |
| Biological Activity: | Selective Na + , K + -ATPase inhibitor. |
| Flash Point: | 306°C |
| Color: | white |
| Safety Data | |
 |
|
